Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial-Reference-Cited by-同舟云学术

Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial

Published:2001-01 Issue:1 Volume:57 Page:55-59
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Otto Thomas,Krege Susanne,Suhr Julia,Rübben Herbert

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. M-VAC for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol,1988

2. Combination therapy with Taxol and carboplatin in advanced transitional cell cancer;Roigas;J Urol,2000

3. Cisplatin, gemcitabine and paclitaxel chemotherapy of advanced bladder cancer;Klein;J Urol,2000

4. Second-line chemotherapy with every 2-week gemcitabine and paclitaxel in previously treated patients with transitional cell carcinoma;Sternberg;J Urol,2000

5. Gemcitabine monotherapy as 2nd-line treatment in cisplatin refractory transitional cell carcinoma;Albers;J Urol,2000

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unusual metastasis after radical cystectomy: case report;Journal of Surgical Case Reports;2024-03

2. Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology;Current Opinion in Urology;2024-02-29

3. Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis;Cancers;2023-02-11

4. The oligometastatic spectrum in the era of improved detection and modern systemic therapy;Nature Reviews Clinical Oncology;2022-07-12

5. The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery;Cancer Research and Treatment;2022-01-15